KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments

Posted on Mar 02, 2021, 3 p.m.


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.


The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta-lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.  


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta-lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://www.worldhealth.net/news/antibiotic-tolerance-study-paves-way-new-treatments/


List of Articles
번호 제목 글쓴이 날짜 조회 수
370 홍성태 박사, 하국선 박사, 2011년도 이공분야 "학문후속양성사업" 선정! 과사무실 2011.09.16 15001
369 최길주 교수, Plant Cell 2월호에 논문 게재 과사무실 2009.04.02 14992
368 한진희 교수, 원혜정 학생(김은준 교수 Lab) 2009' 청암 과학펠로 선정! 과사무실 2009.11.27 14924
367 최길주 교수, PNAS(P Natl Acad Sci USA) 4월호에 논문 게재 과사무실 2009.04.23 14796
366 홍철암 박사과정(김학성 교수 Lab), ICMAT 2011에서 The Best Poster Award 수상! 과사무실 2011.07.06 14764
365 김진우 교수 경력개발상 수상 과사무실 2007.04.10 14714
364 김은준 교수 창의과제 신규 선정 과사무실 2003.09.08 14694
363 최광욱 교수, 홍성태 박사 Nature Communications 논문 게재(2016.09) / Prof. Kwang-Wook Choi and Dr. Sung-Tae Hong published a paper in Nature Communications 생명과학과 2016.10.06 14691
362 강창원, 김은준 교수팀, ADHD 유전자 찾았다 과사무실 2011.04.18 14617
361 [동아일보] 한국 과학에 세계가 또 놀라다 -정종경교수팀 과사무실 2006.05.04 14541
360 임대식 최길주 교수 승진 인사발령 과사무실 2004.09.01 14539
359 임대식 교수, 김민철 박사 Cell Reports 에 논문 게재(2015.03) / Professor Dae-Sik Lim and Min Cheol Kim, Ph.D Publish in Cell Reports (2015.03) 과사무실 2015.04.06 14453
358 송지준 교수, PNAS 게재 (2012.8) 과사무실 2012.12.10 14411
357 김대수 교수 생명과학과 부임 과사무실 2004.09.01 14402
356 송지준 교수, 김은지 박사 Molecular Cell에 논문 게재(2015) / Prof. Ji-Joon Song and PhD. Eun-Ji Kim published a paper at Molecular Cell (2015) 과사무실 2015.07.29 14393
355 허원도 교수, Nature Communications지 논문 게재 (2014. 6) 과사무실 2014.06.05 14305
354 김은준 교수 연구팀, 자폐증 치료 가능성 열어 과사무실 2012.06.15 14304
353 [매일경제] 김은준 교수"퍼즐놀이하듯 신경세포 연구" 과사무실 2003.09.23 14298
352 KAIST 김태국 교수 신약개발 사이언스지 발표 과사무실 2005.07.01 14256
351 서연수 교수 생명과학상 수상 과사무실 2003.09.08 14251
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 22 Next
/ 22